50878-03-0 Usage
General Description
5,6,7,8-Tetrahydronaphthalene-2-yl-acetamide (THN2A) is a chemical compound that belongs to the class of organic compounds known as tetrahydronaphthalenes. This class of chemical compounds contains a tetrahydronaphthalene moiety, which is a polycyclic aromatic hydrocarbon made up of two fused cyclohexane rings. 5,6,7,8-Tetrahydronaphthalene-2-yl-acetamide is generally considered to be a practically insoluble (in water) and relatively neutral molecule. The chemical is not observed to exist naturally in a significant concentration but is synthesized instead. Its potential applications, reactions, uses, and overall behavior are subject to ongoing studies. Note that precise information may vary depending on the specific context under which this chemical is analyzed or applied.
Check Digit Verification of cas no
The CAS Registry Mumber 50878-03-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,8,7 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 50878-03:
(7*5)+(6*0)+(5*8)+(4*7)+(3*8)+(2*0)+(1*3)=130
130 % 10 = 0
So 50878-03-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO/c1-9(14)13-12-7-6-10-4-2-3-5-11(10)8-12/h6-8H,2-5H2,1H3,(H,13,14)
50878-03-0Relevant articles and documents
-
Ward,Coulson
, p. 4545 (1954)
-
Visible-light-induced Beckmann rearrangement by organic photoredox catalysis
Tang, Li,Wang, Zhi-Lv,Wan, Hai-Lan,He, Yan-Hong,Guan, Zhi
supporting information, p. 6182 - 6186 (2020/09/01)
A facile and general strategy for efficient direct conversion of oximes to amides using an inexpensive organic photocatalyst and visible light is described. This radical Beckmann rearrangement can be performed under mild conditions. Various alkyl aryl ketoximes and diaryl ketoximes can be effectively converted into the corresponding amides in excellent yields.
COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR
-
Paragraph 0378, (2019/10/15)
Disclosed are compounds of Formula (I) and (Ia) or a pharmaceutically acceptable salt, a solvate, a tautomer, a stereoisomer or a deuterated analog thereof, wherein R4, R5, R6, and R7 are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.